Skip to content

Clinical trials

Head and Neck Neoplasms trials in Belgium

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Head and Neck Neoplasms Country / region: Belgium Clear all

108 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20014
20031
20042
20051
20064
20075
20085
20093
20102
20111
20125
20136
20143
20156
20163
20179
20183
20194
20209
20218
20224
20234
20245
20253
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed52
Terminated16
Active, not recruiting14
Recruiting12
Unknown status8
Withdrawn3
Not yet recruiting2
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
European Organisation for Research and Treatment of Cancer - EORTC11
University Hospital, Ghent11
Universitaire Ziekenhuizen KU Leuven6
Cliniques universitaires Saint-Luc- Université Catholique de Louvain5
Jules Bordet Institute5
AstraZeneca4
Genmab4
Hoffmann-La Roche4
Boehringer Ingelheim3
Eli Lilly and Company3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Head and Neck Neoplasms108
Squamous Cell Carcinoma of Head and Neck27
Carcinoma, Non-Small-Cell Lung13
Breast Neoplasms12
Neoplasms12
Melanoma10
Lung Neoplasms9
Ovarian Neoplasms9
Carcinoma, Squamous Cell8
Prostatic Neoplasms8

Trials

Showing 51 to 75 of 108. Each trial links to its page on Pharma Observatory.

8 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.